Coventry Outcomes Study of Seniors (COSS): A Comparative Effectiveness Study to Evaluate the Effect of a Multidisciplinary Team's Intervention on the Incidence of Nonelective Hospitalizations in a Medicare Population

NCT ID: NCT01014884

Last Updated: 2010-01-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

2150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-11-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators are studying the impact of the interventions of a multidisciplinary team (MDT) - consisting of a Coventry case manager, social worker, and medical director, alongside a Medco specialist pharmacist - on the hospitalization rates of high risk seniors with chronic conditions, compared with a usual care approach. The study will also examine the impact on quality of life, medication adherence, medical costs, hospital readmission rates, and a variety of other important measures. The outcome of COSS may support a means to further enhance and develop a comprehensive care model program by leveraging the partnership between a health plan and a pharmacy benefit manager.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The multidisciplinary team will provide face-to-face visits in a home setting with interventions that focus on five key areas: care transitions, self-management, care coordination, pharmacy and prevention, all designed to support high-risk Medicare members and their relationship with their primary care providers. If the study proves to reduce hospitalizations in the senior population, it could provide important guidance for future efforts to reduce the cost and improve the quality of care for seniors with chronic conditions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure Chronic Obstructive Pulmonary Disease Cardiovascular Disease Diabetes Osteoporosis

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Group

The control group will receive usual care as provided by your Health Plan.

Group Type OTHER

Usual case management and pharmacy management as provided by the health Plan and the pharmacy benefit manager

Intervention Type OTHER

Intervention group

Additional visits will be conducted by a member of the multidisciplinary team (case manager/nurse, social worker and/or pharmacist that will be either face to face or by telephone.

Group Type OTHER

Multidisciplinary team interventions

Intervention Type OTHER

The multidisciplinary team will determine which intervention should be applied to the participant in the intervention group based on their health risk assessment responses as well as medication review and visual inspection of the home.

Multidisciplinary team bimonthly visits either in person or via telephone.

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multidisciplinary team interventions

The multidisciplinary team will determine which intervention should be applied to the participant in the intervention group based on their health risk assessment responses as well as medication review and visual inspection of the home.

Intervention Type OTHER

Multidisciplinary team bimonthly visits either in person or via telephone.

Intervention Type OTHER

Usual case management and pharmacy management as provided by the health Plan and the pharmacy benefit manager

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Inouye Risk Score \>3 calculated on Coventry Claims
* Medicare Advantage beneficiaries age \> 65 years
* Continuous eligibility \> 12 months prior to study
* Ability to be contacted via telephone
* Subject is willing and able to provide informed consent
* Willing to comply with all study procedures and be available for the duration of the study

Exclusion Criteria

* Active cancer treatment (i.e. chemotherapy or radiation) in the past 6 months
* Living anywhere other than a community setting \[i.e. Skilled nursing facility (SNF)\]
* Just-In-Time (JIT) Members
* Members with a geographic location \> 60 from either St. Louis or Kansas City, MO.
* Solid organ transplant recipients
* Active enrollment in another clinical research study
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coventry Health Care, Inc.

INDUSTRY

Sponsor Role collaborator

Medco Health Solutions, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Medco Health Solutions, Inc.

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Julia O McEachern, MHS, PA-C

Role: PRINCIPAL_INVESTIGATOR

Medco Health Solutions, Inc.

Stephen L Cavalieri, MD

Role: PRINCIPAL_INVESTIGATOR

Coventry Health Care, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kansas City, Missouri, United States

Site Status

St Louis, Missouri, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7714

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

YouScript IMPACT Registry
NCT02191358 COMPLETED